Neisseria meningitidis composition and methods thereof
US10550159B2 · kind B2 · utility
10Cited by
79References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2018 |
| Grant date | Feb 4, 2020 |
| Priority date | — |
| Expiry date | Dec 3, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the invention relates to a non-lipidated and non-pyruvylated Neisseria meningitidis serogroup B polypeptide and methods of use thereof. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.